CXCL12 expression is an independent prognostic factor for aggressive phenotypes of GC, including tumor size, invasion depth, lymphatic invasion and metastasis, TNM staging, surgical outcome, and the OS 22, 24, 25. Here, CXCL12 is linked to neoplasm.